These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 8589295)
1. Deposition of kappa and lambda light chains in amyloid filaments of dialysis-related amyloidosis. Brancaccio D; Ghiggeri GM; Braidotti P; Garberi A; Gallieni M; Bellotti V; Zoni U; Gusmano R; Coggi G J Am Soc Nephrol; 1995 Oct; 6(4):1262-70. PubMed ID: 8589295 [TBL] [Abstract][Full Text] [Related]
2. Beta 2-microglobulin amyloidosis in hemodialysis patients. An autopsy study of intervertebral disks and posterior longitudinal ligaments. Honda K; Hara M; Ogura Y; Nihei H; Mimura N Acta Pathol Jpn; 1990 Nov; 40(11):820-6. PubMed ID: 2127652 [TBL] [Abstract][Full Text] [Related]
3. Ultrastructural evidence for colocalization of kappa light chain- and beta 2-microglobulin-derived amyloids using double labelling immunogold electron microscopy. Takahashi M; Hoshii Y; Kawano H; Gondo T; Ishihara T; Isobe T Virchows Arch; 1996 Dec; 429(6):383-8. PubMed ID: 8982384 [TBL] [Abstract][Full Text] [Related]
4. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis. Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025 [TBL] [Abstract][Full Text] [Related]
5. Related bindings of aggregated beta 2-microglobulin, IgG Fab, kappa and lambda light chains to group A streptococci. Persson MH; Schalén C; Berggård B; Lögdberg L; Björck L Acta Pathol Microbiol Immunol Scand B; 1986 Feb; 94(1):25-31. PubMed ID: 3088909 [TBL] [Abstract][Full Text] [Related]
6. Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy. Silver MM; Hearn SA; Walton JC; Lines LA; Walley VM Am J Pathol; 1990 May; 136(5):997-1007. PubMed ID: 1693473 [TBL] [Abstract][Full Text] [Related]
7. Coexistence of beta2 microglobulin and lambda light chain in amyloid fibrils of dialysis-unrelated plasma cell dyscrasia-associated systemic amyloidosis. Fujimoto N; Wada N; Akiyama M; Tajima S; Ishibashi A; Miyakawa S Br J Dermatol; 2002 Sep; 147(3):549-53. PubMed ID: 12207599 [TBL] [Abstract][Full Text] [Related]
8. Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats. Kadota A; Iwaide S; Miyazaki S; Mitsui I; Machida N; Murakami T Vet Pathol; 2020 Sep; 57(5):658-665. PubMed ID: 32880234 [TBL] [Abstract][Full Text] [Related]
9. [Mixed type amyloidomas, beta2 microglobulin and AL lambda, in a long term hemodialysis patient]. Menet E; Petit ML; Bridoux F; Touchard G; Duport G; Levillain P; Babin P Nephrologie; 2001; 22(3):115-8. PubMed ID: 11436666 [TBL] [Abstract][Full Text] [Related]
10. Roles of immunoglobulins in amyloidogenesis in cutaneous nodular amyloidosis. Ito K; Hashimoto K; Kambe N; Van S J Invest Dermatol; 1987 Oct; 89(4):415-8. PubMed ID: 3117902 [TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis. Fujimoto N; Yajima M; Ohnishi Y; Tajima S; Ishibashi A; Hata Y; Enomoto U; Konohana I; Wachi H; Seyama Y J Invest Dermatol; 2002 Mar; 118(3):479-84. PubMed ID: 11874487 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain. Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965 [TBL] [Abstract][Full Text] [Related]
13. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes. Harris DL; King E; Ramsland PA; Edmundson AB J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557 [TBL] [Abstract][Full Text] [Related]
14. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient. Stokes MB; Jagirdar J; Burchstin O; Kornacki S; Kumar A; Gallo G Mod Pathol; 1997 Oct; 10(10):1059-65. PubMed ID: 9346188 [TBL] [Abstract][Full Text] [Related]
15. Alpha 2-macroglobulin protects some of the protein constituents of dialysis-associated amyloidosis from protease degradation. Gouin-Charnet A; Mourad G; Argilés A Biochem Biophys Res Commun; 1997 Feb; 231(1):48-51. PubMed ID: 9070217 [TBL] [Abstract][Full Text] [Related]
16. [Histological and immunohistochemical examinations in the diagnosis of hepatic amyloidosis]. Mikhaleva LM; Gioeva ZV; Rёken K Arkh Patol; 2015; 77(4):11-16. PubMed ID: 26485775 [TBL] [Abstract][Full Text] [Related]
17. Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production. Laeng RH; Altermatt HJ; Scheithauer BW; Zimmermann DR Cancer; 1998 Jan; 82(2):362-74. PubMed ID: 9445195 [TBL] [Abstract][Full Text] [Related]
18. A clinicopathological analysis in a large cohort of Chinese patients with renal amyloid light-chain amyloidosis. Yao Y; Wang SX; Zhang YK; Qu Z; Liu G; Zou WZ Nephrol Dial Transplant; 2013 Mar; 28(3):689-97. PubMed ID: 23182813 [TBL] [Abstract][Full Text] [Related]
19. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis. Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976 [TBL] [Abstract][Full Text] [Related]
20. Polymerization of normal and intact beta 2-microglobulin as the amyloidogenic protein in dialysis-amyloidosis. Campistol JM; Bernard D; Papastoitsis G; Solé M; Kasirsky J; Skinner M Kidney Int; 1996 Oct; 50(4):1262-7. PubMed ID: 8887286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]